Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXD2AT
|
||||
| Drug Name |
2-((4-(1H-indol-3-yl)-5,6-dihydropyridin-1(2H)-yl)methyl)-3,4-dihydro-2H-benzo[b][1,4]oxazine
|
||||
| Synonyms |
CHEMBL205031
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C22H23N3O
|
||||
| Canonical SMILES |
C(C1CNc2ccccc2O1)N3CCC(=CC3)c4c[nH]c5ccccc45
|
||||
| InChI |
InChI=1S/C22H23N3O/c1-2-6-20-18(5-1)19(14-24-20)16-9-11-25(12-10-16)15-17-13-23-21-7-3-4-8-22(21)26-17/h1-9,14,17,23-24H,10-13,15H2
|
||||
| InChIKey |
VSXPSCOXEGOPID-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.